Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tralokinumab in Uncontrolled Moderate-to-Severe Persistent Asthma
NCT00873860Phase 2Completed
- Sponsor
- MedImmune
- Start
- Jun 2009
- Primary completion
- Aug 2010
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of tralokinumab in asthma, sponsored by MedImmune. Started Jun 2009; status: completed.
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00873860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873860.